Sarepta Therapeutics Inc (NASDAQ:SRPT)

62.23
BATS BZX Real-Time Price
As of 12:08pm ET
 -0.78 / -1.24%
Today’s Change
28.14
Today|||52-Week Range
68.90
+11.84%
Year-to-Date
BioMarin (BMRN) Q4 Loss Wider Than Expected, Sales Beat
10:03am / Zacks.com - Paid Partner Content
Sound Familiar? Dovish Fed Talk Induces Stock Reversal
Feb 22 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close63.01
Today’s open63.31
Day’s range61.90 - 63.38
Volume12,601
Average volume (3 months)1,711,034
Market cap$4.1B
Data as of 12:08pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+86.01%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book10.25

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...+0.14+0.17%
LOXOLoxo Oncology Inc-0.93-0.84%
RAREUltragenyx Pharmaceu...-0.47-0.99%
IRWDIronwood Pharmaceuti...-0.14-0.94%
Data as of 12:11pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts